Post Archive by Day

The current rapid spread of the monkeypox virus and other pathogens shows just how important it is to invest early in disease research so that we can be better prepared for future infectious disease threats, whenever or wherever they may strike, wrote GAVI.
On October 10, 2022, Jodie Rogers wrote one such disease with epidemic potential is Rift Valley fever, which was initially identified in the 1930s,
Spread by a virus of the same name, this potentially deadly Rift Valley fever causes periodic outbreaks across Africa and parts of the Arabian Peninsula.

Recent announcements indicate innovative technologies may provide new clinical solutions for the 36.9 million people living with HIV/AIDS worldwide. 
The current standard of care for these people of all ages is a combination of antiretroviral therapies, which may control the disease, but are not curative, as they cannot target integrated HIV-1 genomes, says HIV.gov.
Recently, a potential cure for human immunodeficiency virus type 1 (HIV-1) created with CRISPR-based editing of HIV proviral DNA was announced.

After five years of clinical research, a new dengue vaccine may soon become available throughout Europe. 
The European Medicines Agency (EMA) human medicines committee adopted a positive opinion for QDENGA® (TAK-003) Dengue Tetravalent Vaccine (live, attenuated) on October 14, 2022.

The Bill & Melinda Gates Foundation announced yesterday it would commit $1.2 billion to support efforts to end all forms of polio globally.
The new financial commitment announced on October 16, 2022, supports the implementation of the Global Polio Eradication Initiative (GPEI) Polio Eradication Strategy 2022-2026, which aims to end wild poliovirus in the last two endemic countries—Pakistan and Afghanistan.
Another concern is that countries that had previously eliminated all forms of poliovirus have recently reported new detections in wastewater systems.